NAGE - Niagen Bioscience Inc
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$10.50
DETAILS
HIGH:
$11.00
LOW:
$10.00
MEDIAN:
$10.50
CONSENSUS:
$10.50
UPSIDE:
186.89%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||
| Revenue | 129.4 | 99.6 | 83.6 | 72.0 | 67.4 | 59.3 | 46.3 | 31.6 | 21.2 | 21.7 | 17.9 | 15.3 | 10.2 | 11.6 | 8.1 | 7.6 | 5.8 | 4.5 | 0 |
| Cost of Revenue | 46.2 | 38.0 | 32.8 | 29.3 | 26.0 | 24.0 | 20.5 | 15.5 | 10.7 | 11.3 | 10.4 | 10.0 | 7.0 | 9.3 | 5.6 | 4.6 | 3.7 | 3.3 | 0 |
| Gross Profit | 83.2 | 61.6 | 50.8 | 42.8 | 41.5 | 35.3 | 25.8 | 16.1 | 10.5 | 10.4 | 7.5 | 5.3 | 3.1 | 2.3 | 2.5 | 2.9 | 2.0 | 1.2 | 0 |
| Operating Expenses | |||||||||||||||||||
| R&D Expenses | 6.3 | 6.0 | 5.0 | 4.8 | 3.8 | 3.4 | 4.4 | 5.5 | 4.0 | 2.5 | 0.9 | 0.5 | 0.1 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A Expenses | 62.6 | 47.8 | 51.4 | 56.6 | 64.7 | 51.7 | 52.5 | 43.7 | 22.1 | 10.8 | 8.7 | 10.0 | 7.3 | 13.9 | 10.3 | 5.0 | 2.9 | 3.3 | 0.0 |
| Other Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0.1 | 0.1 | 0.7 | 0 | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | 68.9 | 53.9 | 56.4 | 61.4 | 68.6 | 55.1 | 57.1 | 49.2 | 26.9 | 13.3 | 9.6 | 10.6 | 7.5 | 13.9 | 10.3 | 5.0 | 2.9 | 3.3 | 0.0 |
| Operating Income | |||||||||||||||||||
| Operating Income | 14.3 | 7.7 | (5.6) | (18.6) | (27.1) | (19.9) | (31.3) | (33.2) | (16.4) | (2.9) | (2.1) | (5.2) | (4.4) | (11.6) | (7.9) | (2.0) | (0.9) | (2.1) | (0.0) |
| Interest Expense | 0 | 0 | 0 | 0 | 0.1 | 0.1 | 0.8 | 0.1 | 0.2 | 0.4 | 0.6 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0 |
| Interest Income | 2.1 | 1.1 | 0.7 | 0.0 | 0 | 0 | 0 | 0 | 0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0 |
| Profitability | |||||||||||||||||||
| EBITDA | 15.7 | 9.2 | (3.9) | (16.7) | (25.4) | (18.3) | (29.8) | (32.3) | (15.7) | (2.5) | (1.7) | (5.0) | (4.1) | (11.3) | (7.5) | (1.6) | (0.5) | (1.7) | (0.0) |
| EBIT | 14.3 | 7.7 | (5.6) | (18.6) | (27.1) | (19.9) | (31.3) | (33.2) | (16.4) | (2.9) | (2.1) | (5.2) | (4.4) | (11.6) | (7.9) | (2.0) | (0.9) | (2.1) | (0.0) |
| Income Before Tax | 18.2 | 8.9 | (4.9) | (16.5) | (27.1) | (19.9) | (32.1) | (33.3) | (16.5) | (3.6) | (2.6) | (5.4) | (4.4) | (11.7) | (7.9) | 0 | 0 | 0 | 0 |
| Income Tax Expense | 0.8 | 0.3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.0 | 0 | 0 | 0 | 0 | 2.1 | 0.9 | 2.1 | 0.0 |
| Net Income | 17.4 | 8.6 | (4.9) | (16.5) | (27.1) | (19.9) | (32.1) | (33.3) | (11.4) | (2.9) | (2.8) | (5.4) | (4.4) | (11.7) | (7.9) | (2.1) | (0.9) | (2.1) | (0.0) |
| Per Share Data | |||||||||||||||||||
| EPS (Basic) | 0.22 | 0.10 | -0.07 | -0.24 | -0.40 | -0.33 | -0.56 | -0.61 | -0.26 | -0.08 | -0.08 | -0.15 | -0.13 | -0.39 | -0.35 | -0.13 | -0.09 | -0.22 | -0.01 |
| EPS (Diluted) | 0.20 | 0.11 | -0.07 | -0.24 | -0.40 | -0.33 | -0.56 | -0.61 | -0.26 | -0.08 | -0.08 | -0.15 | -0.13 | -0.36 | -0.35 | -0.13 | -0.09 | -0.22 | -0.01 |
| Shares Outstanding | 79.2 | 85.4 | 70.5 | 68.9 | 67.2 | 61.1 | 57.1 | 55.0 | 44.6 | 37.3 | 35.9 | 35.5 | 33.3 | 30.1 | 22.8 | 16.1 | 9.6 | 9.4 | 5.3 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||||||
| Cash & Cash Equivalents | 64.8 | 44.5 | 27.2 | 20.3 | 28.0 | 16.5 | 18.6 | 22.4 | 45.4 | 1.6 | 0.5 | 1.1 |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 9.7 | 7.8 | 5.2 | 8.5 | 5.2 | 2.7 | 2.2 | 4.4 | 5.3 | 5.9 | 0.5 | 0.3 |
| Inventory | 20.4 | 9.2 | 14.5 | 14.7 | 13.6 | 11.7 | 11.5 | 8.2 | 5.8 | 7.9 | 0.9 | 0.7 |
| Other Current Assets | 1.9 | 2.6 | 2.6 | 3.1 | 0.2 | 0.2 | 0.2 | 0.9 | 0 | 0.0 | 0 | 0 |
| Total Current Assets | 96.8 | 64.1 | 49.5 | 46.6 | 48.9 | 32.2 | 33.5 | 36.5 | 57.2 | 15.7 | 2.0 | 2.3 |
| Non-Current Assets | ||||||||||||
| Property, Plant & Equipment | 3.5 | 3.4 | 4.5 | 6.3 | 7.4 | 4.4 | 4.7 | 3.6 | 2.9 | 1.8 | 1.2 | 1.3 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 5.7 | 0.4 | 0.5 | 0.7 | 0.9 | 1.1 | 1.3 | 1.5 | 1.7 | 0.5 | 0.3 | 0.4 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.0 | 0 | 0 |
| Other Non-Current Assets | 0.4 | 0.4 | 0.4 | 0.5 | 0.7 | 0.6 | 0.8 | 0.6 | 1.0 | 1.7 | 0.0 | 0.0 |
| Total Non-Current Assets | 9.6 | 4.2 | 5.4 | 7.5 | 8.9 | 6.1 | 6.7 | 5.7 | 5.5 | 4.0 | 1.6 | 1.8 |
| Total Assets | 106.4 | 68.3 | 55.0 | 54.1 | 57.8 | 38.4 | 40.2 | 42.2 | 62.7 | 19.8 | 3.6 | 4.1 |
| Current Liabilities | ||||||||||||
| Account Payables | 10.8 | 8.5 | 10.2 | 9.7 | 10.4 | 9.4 | 9.6 | 9.5 | 3.7 | 6.0 | 0.5 | 0.4 |
| Short-Term Debt | 1.0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0.6 | 0.2 | 0.2 | 0.2 | 0.3 | 0.2 | 0.3 | 0.3 | 0.4 | 0.2 | 0.0 |
| Other Current Liabilities | 8.1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.1 | 0.1 | 0 | 0 |
| Total Current Liabilities | 19.9 | 17.9 | 20.6 | 17.9 | 17.6 | 16.5 | 15.1 | 14.4 | 8.1 | 8.9 | 2.2 | 2.1 |
| Non-Current Liabilities | ||||||||||||
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 5.5 | 0 | 0 | 0 | 0 | 0 | 0 | 0.5 | 0.5 | 0.6 | 0 | 0 |
| Total Non-Current Liabilities | 10.0 | 4.2 | 5.9 | 7.5 | 8.5 | 5.5 | 4.7 | 0.6 | 0.8 | 0.9 | 0.3 | 0.3 |
| Total Liabilities | 29.9 | 22.2 | 26.5 | 25.4 | 26.1 | 21.9 | 19.8 | 15.1 | 8.9 | 9.8 | 2.5 | 2.3 |
| Stockholders' Equity | ||||||||||||
| Common Stock | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 |
| Retained Earnings | (164.5) | (181.9) | (190.5) | (185.5) | (169.0) | (141.8) | (121.9) | (89.8) | (56.6) | (45.2) | (8.1) | (7.2) |
| Accumulated Other Comprehensive Income | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Stockholders' Equity | 76.5 | 46.1 | 28.5 | 28.7 | 31.7 | 16.4 | 20.4 | 27.2 | 53.8 | 10.0 | 1.0 | 1.7 |
| Total Liabilities & Equity | 106.4 | 68.3 | 55.0 | 54.1 | 57.8 | 38.4 | 40.2 | 42.2 | 62.7 | 19.8 | 3.6 | 4.1 |
| Debt Metrics | ||||||||||||
| Total Debt | 2.8 | 2.7 | 3.3 | 4.3 | 4.7 | 1.6 | 1.7 | 0.3 | 0.5 | 0.6 | 0.1 | 0.2 |
| Net Debt | (62.0) | (41.9) | (23.9) | (16.0) | (23.3) | (14.9) | (16.9) | (22.1) | (44.9) | (1.0) | (0.4) | (1.0) |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||
| Net Income | 17.4 | 8.6 | (4.9) | (16.5) | (27.1) | (19.9) | (32.1) | (33.3) | (11.4) | (2.9) |
| Depreciation & Amortization | 1.4 | 1.5 | 1.7 | 1.9 | 1.6 | 1.5 | 1.5 | 0.8 | 0.7 | 0.4 |
| Stock-Based Compensation | 0 | 3.7 | 4.8 | 5.7 | 6.2 | 6.9 | 7.2 | 6.4 | 4.6 | 1.2 |
| Change in Working Capital | (8.3) | 3.1 | 4.6 | (6.0) | (4.7) | 1.1 | 0.4 | 5.2 | 2.0 | (2.8) |
| Other Non-Cash Items | 2.9 | (4.7) | 1.0 | (0.2) | (0.1) | (0.2) | 2.6 | 0.0 | (5.8) | 1.1 |
| Operating Cash Flow | 13.4 | 12.1 | 7.1 | (15.1) | (24.2) | (10.6) | (20.4) | (20.9) | (9.8) | (2.9) |
| Investing Activities | ||||||||||
| Capital Expenditure | (0.3) | (0.2) | (0.1) | (0.3) | (0.4) | (0.1) | (0.8) | (1.5) | (1.4) | (1.7) |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales/Maturities of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0.0 | 0.0 | 0 | 0 | (0.0) | 0.5 | (0.5) | 5.8 | (0.2) |
| Investing Cash Flow | (0.3) | (0.1) | (0.1) | (0.3) | (0.4) | (0.2) | (0.2) | (1.8) | 4.6 | (1.7) |
| Financing Activities | ||||||||||
| Net Debt Issuance | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.3) | 9.7 | (0.2) | (0.6) | (5.2) |
| Stock Repurchased | (0.3) | 0 | 0 | 0 | 0 | 0 | 0 | (0.4) | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | (0.1) | (0.1) | (0.1) | 9.4 | 4.1 | 0.4 | 0.5 | 3.0 | 0.3 |
| Financing Cash Flow | 7.0 | 5.4 | (0.1) | 7.7 | 36.1 | 8.7 | 16.9 | (0.1) | 48.9 | 0.8 |
| Cash Position | ||||||||||
| Net Change in Cash | 20.1 | 17.3 | 6.9 | (7.8) | 11.5 | (2.1) | (3.8) | (22.8) | 43.7 | (3.9) |
| Cash at Beginning | 44.7 | 27.3 | 20.4 | 28.2 | 16.7 | 18.8 | 22.6 | 45.4 | 1.6 | 5.5 |
| Cash at End | 64.8 | 44.7 | 27.3 | 20.4 | 28.2 | 16.7 | 18.8 | 22.6 | 45.4 | 1.6 |
| Free Cash Flow | 13.1 | 11.9 | 7.0 | (15.4) | (24.6) | (10.7) | (21.2) | (22.4) | (11.2) | (4.7) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||||||||||
| Revenue | 129.4 | 99.6 | 83.6 | 72.0 | 67.4 | 59.3 | 46.3 | 31.6 | 21.2 | 21.7 | 17.9 | 15.3 | 10.2 | 11.6 | 8.1 | 7.6 | 5.8 | 4.5 | 0 |
| Gross Profit | 83.2 | 61.6 | 50.8 | 42.8 | 41.5 | 35.3 | 25.8 | 16.1 | 10.5 | 10.4 | 7.5 | 5.3 | 3.1 | 2.3 | 2.5 | 2.9 | 2.0 | 1.2 | 0 |
| Operating Income | 14.3 | 7.7 | (5.6) | (18.6) | (27.1) | (19.9) | (31.3) | (33.2) | (16.4) | (2.9) | (2.1) | (5.2) | (4.4) | (11.6) | (7.9) | (2.0) | (0.9) | (2.1) | (0.0) |
| Net Income | 17.4 | 8.6 | (4.9) | (16.5) | (27.1) | (19.9) | (32.1) | (33.3) | (11.4) | (2.9) | (2.8) | (5.4) | (4.4) | (11.7) | (7.9) | (2.1) | (0.9) | (2.1) | (0.0) |
| EPS (Diluted) | 0.20 | 0.11 | -0.07 | -0.24 | -0.40 | -0.33 | -0.56 | -0.61 | -0.26 | -0.08 | -0.08 | -0.15 | -0.13 | -0.36 | -0.35 | -0.13 | -0.09 | -0.22 | -0.01 |
| Balance Sheet | |||||||||||||||||||
| Cash & Equivalents | 64.8 | 44.5 | 27.2 | 20.3 | 28.0 | 16.5 | 18.6 | 22.4 | 45.4 | 1.6 | 0.5 | 1.1 | |||||||
| Total Assets | 106.4 | 68.3 | 55.0 | 54.1 | 57.8 | 38.4 | 40.2 | 42.2 | 62.7 | 19.8 | 3.6 | 4.1 | |||||||
| Total Debt | 2.8 | 2.7 | 3.3 | 4.3 | 4.7 | 1.6 | 1.7 | 0.3 | 0.5 | 0.6 | 0.1 | 0.2 | |||||||
| Stockholders' Equity | 76.5 | 46.1 | 28.5 | 28.7 | 31.7 | 16.4 | 20.4 | 27.2 | 53.8 | 10.0 | 1.0 | 1.7 | |||||||
| Cash Flow | |||||||||||||||||||
| Operating Cash Flow | 13.4 | 12.1 | 7.1 | (15.1) | (24.2) | (10.6) | (20.4) | (20.9) | (9.8) | (2.9) | |||||||||
| Capital Expenditure | (0.3) | (0.2) | (0.1) | (0.3) | (0.4) | (0.1) | (0.8) | (1.5) | (1.4) | (1.7) | |||||||||
| Free Cash Flow | 13.1 | 11.9 | 7.0 | (15.4) | (24.6) | (10.7) | (21.2) | (22.4) | (11.2) | (4.7) | |||||||||